Publication:
Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry.

dc.contributor.authorBorjas Howard, Jaime
dc.contributor.authorRuiz-Sada, Pablo
dc.contributor.authorde Leeuw, Karina
dc.contributor.authorLópez-Jiménez, Luciano
dc.contributor.authorFont, Carme
dc.contributor.authorMarchena, Pablo Javier
dc.contributor.authorMadridano, Olga
dc.contributor.authorDebourdeau, Philippe
dc.contributor.authorMeijer, Karina
dc.contributor.authorMonreal, Manuel
dc.contributor.authorRegistro Informatizado de Enfermedad TromboEmbólica (RIETE) Investigators
dc.date.accessioned2023-02-09T11:39:52Z
dc.date.available2023-02-09T11:39:52Z
dc.date.issued2021-06-02
dc.description.abstractAutoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those without (n = 50608). Overall rates were 6.5 and 5.1 recurrent VTE/100 years for patients with autoimmune disease vs controls, respectively. After adjustment for sex and unprovoked/provoked VTE yielded an adjusted hazard ratio of 1.29 (95%CI 1.03-1.62). The analysis was limited by short median follow up time (161 days overall), precluding definitive conclusions on recurrent VTE risks.
dc.identifier.doi10.1111/bjh.17549
dc.identifier.essn1365-2141
dc.identifier.pmcPMC8362114
dc.identifier.pmid34075574
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362114/pdf
dc.identifier.unpaywallURLhttps://pure.rug.nl/ws/files/173466961/Risk_of_recurrent_venous_thromboembolism_in_patients_with_autoimmune_diseases_data_from_the_Registro_Informatizado_de_Enfermedad_TromboEmb_lica_RIETE_registry.pdf
dc.identifier.urihttp://hdl.handle.net/10668/17942
dc.issue.number1
dc.journal.titleBritish journal of haematology
dc.journal.titleabbreviationBr J Haematol
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationHospital Universitario Reina Sofía
dc.page.number195-199
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectautoimmune disease
dc.subjectrisk factors
dc.subjectvenous thrombosis
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshAnticoagulants
dc.subject.meshAutoimmune Diseases
dc.subject.meshConfounding Factors, Epidemiologic
dc.subject.meshEurope
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshIncidence
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshProportional Hazards Models
dc.subject.meshPulmonary Embolism
dc.subject.meshRecurrence
dc.subject.meshRegistries
dc.subject.meshRisk
dc.subject.meshSex Factors
dc.subject.meshVenous Thromboembolism
dc.titleRisk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number194
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8362114.pdf
Size:
96.98 KB
Format:
Adobe Portable Document Format